Mega Lifesciences PCL (BKK:MEGA)
Thailand
· Delayed Price · Currency is THB 33.50
-2.25 (-6.29%)
Mar 9, 2026, 4:39 PM ICT
Mega Lifesciences PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 29,208 | 29,208 | 28,990 | 35,093 | 40,760 | 44,029 | Upgrade
|
| Market Cap Growth | 4.69% | 0.75% | -17.39% | -13.90% | -7.43% | 41.26% | Upgrade
|
| Enterprise Value | 25,248 | 26,052 | 26,452 | 32,883 | 39,242 | 42,440 | Upgrade
|
| Last Close Price | 33.50 | 33.50 | 31.56 | 36.72 | 41.08 | 42.80 | Upgrade
|
| PE Ratio | 15.28 | 15.28 | 14.41 | 17.61 | 18.18 | 22.62 | Upgrade
|
| Forward PE | 12.53 | 13.07 | 11.29 | 14.52 | 17.76 | 22.85 | Upgrade
|
| PS Ratio | 2.06 | 2.06 | 1.88 | 2.23 | 2.59 | 3.11 | Upgrade
|
| PB Ratio | 2.86 | 2.86 | 2.94 | 3.77 | 4.64 | 5.49 | Upgrade
|
| P/TBV Ratio | 3.27 | 3.28 | 3.39 | 4.40 | 5.47 | 6.62 | Upgrade
|
| P/FCF Ratio | 13.87 | 13.87 | 13.46 | 21.25 | 24.09 | 17.10 | Upgrade
|
| P/OCF Ratio | 10.54 | 10.54 | 12.07 | 18.22 | 20.41 | 16.15 | Upgrade
|
| PEG Ratio | 5.69 | 6.26 | 30.40 | 2.85 | 1.36 | 1.41 | Upgrade
|
| EV/Sales Ratio | 1.78 | 1.84 | 1.72 | 2.09 | 2.50 | 3.00 | Upgrade
|
| EV/EBITDA Ratio | 7.82 | 8.26 | 7.32 | 10.45 | 13.45 | 17.84 | Upgrade
|
| EV/EBIT Ratio | 8.56 | 8.83 | 7.76 | 11.19 | 14.42 | 19.48 | Upgrade
|
| EV/FCF Ratio | 11.99 | 12.37 | 12.28 | 19.91 | 23.19 | 16.48 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.05 | 0.03 | 0.05 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.21 | 0.13 | 0.08 | 0.14 | 0.15 | Upgrade
|
| Debt / FCF Ratio | 0.32 | 0.32 | 0.23 | 0.15 | 0.25 | 0.14 | Upgrade
|
| Net Debt / Equity Ratio | -0.39 | -0.39 | -0.34 | -0.27 | -0.27 | -0.27 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.26 | -1.26 | -0.93 | -0.78 | -0.81 | -0.92 | Upgrade
|
| Net Debt / FCF Ratio | -1.88 | -1.88 | -1.56 | -1.49 | -1.41 | -0.85 | Upgrade
|
| Asset Turnover | 0.95 | 0.95 | 1.09 | 1.09 | 1.13 | 1.14 | Upgrade
|
| Inventory Turnover | 2.23 | 2.23 | 2.37 | 2.29 | 2.18 | 2.25 | Upgrade
|
| Quick Ratio | 1.59 | 1.59 | 1.79 | 1.40 | 1.10 | 1.08 | Upgrade
|
| Current Ratio | 2.23 | 2.23 | 2.61 | 2.26 | 1.91 | 1.92 | Upgrade
|
| Return on Equity (ROE) | 19.03% | 19.03% | 20.99% | 22.04% | 26.66% | 25.87% | Upgrade
|
| Return on Assets (ROA) | 12.30% | 12.30% | 15.05% | 12.77% | 12.19% | 10.97% | Upgrade
|
| Return on Invested Capital (ROIC) | 36.71% | 36.76% | 43.75% | 39.14% | 38.39% | 30.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 27.70% | 27.70% | 33.10% | 30.30% | 29.90% | 25.90% | Upgrade
|
| Earnings Yield | 6.55% | 6.55% | 6.94% | 5.68% | 5.50% | 4.42% | Upgrade
|
| FCF Yield | 7.21% | 7.21% | 7.43% | 4.71% | 4.15% | 5.85% | Upgrade
|
| Dividend Yield | 4.48% | 4.78% | 5.07% | 4.36% | 3.90% | 3.23% | Upgrade
|
| Payout Ratio | 72.96% | 72.96% | 69.30% | 72.23% | 62.71% | 47.41% | Upgrade
|
| Total Shareholder Return | 4.48% | 4.78% | 5.07% | 4.36% | 3.90% | 3.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.